Work

Azithromycin or montelukast as inhaled corticosteroid–sparing agents in moderate-to-severe childhood asthma study

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2008.09.028

Authors: Robert C. Strunk, Leonard B. Bacharier, Brenda R. Phillips, Stanley J. Szefler, Robert S. Zeiger, Vernon M. Chinchilli, Fernando D. Martinez, Robert F. Lemanske, Lynn M. Taussig, David T. Mauger, Wayne J. Morgan, Christine A. Sorkness, Ian M. Paul, Theresa Guilbert, Marzena Krawiec, Ronina Covar, Gary Larsen

Institutions: St. Louis Children's Hospital, Washington University in St. Louis, Pennsylvania State University, National Jewish Health, Kaiser Permanente, University of California San Diego, Kaiser Permanente San Diego Medical Center, University of Arizona, University of Wisconsin–Madison

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Sanofi, National Honey Board, Consumer Healthcare Products Association, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: G1650331929, G3893369592, CARE Network--St. Louis Center, G6413956449, G7062379326, G785151132, Pediatric Asthma Network Data coordinating Center

OpenAlex ID: W2037466531

FWCI: 8.034

Cites: 24

Cited by: 134

Related to: 10